Korro Bio (KRRO) Cash from Investing Activities (2018 - 2026)

Korro Bio's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$32.2 million for Q1 2026.

• Quarterly Cash from Investing Activities fell 198.35% year-over-year to -$32.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.0 million (up 75.25% YoY) and the FY2025 annual result came in at $44.0 million, up 135.67% from the prior year.
• Cash from Investing Activities was -$32.2 million for Q1 2026 at Korro Bio, down from $14.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $32.8 million in Q1 2025 and bottomed at -$102.4 million in Q2 2024.
• A 5-year average of -$5.3 million and a median of -$1.7 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities plunged 2892.2% — and 2025, when it jumped 684.23%.
• Korro Bio's Cash from Investing Activities stood at $4.5 million in 2022, then sank by 136.88% to -$1.7 million in 2023, then tumbled by 67.07% to -$2.8 million in 2024, then soared by 639.46% to $14.9 million in 2025, then sank by 316.14% to -$32.2 million in 2026.
• Business Quant data shows KRRO's Cash from Investing Activities at -$32.2 million in Q1 2026, $14.9 million in Q4 2025, and $7.6 million in Q3 2025.